Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Boston Scientific (NY:BSX)

103.41 -1.85 (-1.76%)
Streaming Delayed Price Updated: 10:18 AM EDT, Jun 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Boston Scientific

< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 15 Years
Via Benzinga
Stock Market Diverges, With Tesla, Google, ServiceNow, GE In Focus: Weekly Review
Small caps continued to lead, while the Nasdaq broke below key levels. 
Via Investor's Business Daily
3 Record-Breaking Stocks With More Upside Ahead
Dell, Constellation and Boston Scientific are three record-breaking stocks expected to benefit from the anticipated Fed interest rate cuts. 
Via InvestorPlace
Topics Economy
Exposures Interest Rates
Apple To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
Behind the Scenes of Boston Scientific's Latest Options Trends
Via Benzinga
Performance Comparison: Boston Scientific And Competitors In Health Care Equipment &amp; Supplies Industry
Via Benzinga
US Stocks Tumble, Magnificent 7 Wipe Out $570 Billion As Mega-Tech Earnings Disappoint, VIX Spikes: What's Driving Markets Wednesday?
Wall Street experienced a turbulent session on Wednesday, with the S&P 500 index heading toward its worst performance in over a year and the tech-focused Nasdaq 100 eyeing its fifth decline in the last... 
Via Benzinga
Topics Stocks
Exposures US Equities
Boston Scientific Q2 Earnings: Strong Performance Of Cardiovascular Devices Leads To 2024 Guidance Hike Again
Boston Scientific reported Q2 revenue of $4.12 billion, surpassing estimates. Sales grew 14.5% reported, 16.1% operationally, and 14.7% organically. Adjusted EPS of $0.62 exceeded forecasts. Strong... 
Via Benzinga
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $5,900 Today
Via Benzinga
Peering Into Boston Scientific's Recent Short Interest
Via Benzinga
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $6,100 Today
Via Benzinga
US Stocks Could Open Sharply Lower As Tesla, Alphabet Earnings Offer No Cheer: Analyst Says This Bodes Well For Small-Caps, 'Only Takes A Small Spark To Ignite A Powerful Move'
Wall Street is gearing up for a negative start on Thursday, as traders mull over earnings from Tesla, Inc. (NASDAQ:TSLA) and Alphabet, Inc. 
Via Benzinga
Boston Scientific Earnings Beat, Guidance Raised; Medtech Giant Rises
The medtech giant topped Q2 views and raised full-year guidance. 
Via Investor's Business Daily
Topics Earnings
Exposures Financial
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Unveiling 21 Analyst Insights On Boston Scientific
Via Benzinga
Check Out What Whales Are Doing With BSX
Via Benzinga
7 Robotics Stocks That Could Grow Your Wealth
Explore robotics stocks with the potential to grow investors' wealth as the industry expands across various sectors. 
Via InvestorPlace
BOSTON SCIENTIFIC CORP (NYSE:BSX) showing some interesting technicals. Here's why.
BOSTON SCIENTIFIC CORP (NYSE:BSX) has a good technical rating of 10 out of 10 and could possibly break out. 
Via Chartmill
Critical Insights From Boston Scientific Analyst Ratings: What You Need To Know
Via Benzinga
Staar Surgical Stock Earns RS Rating Upgrade
On Thursday, lens maker Staar Surgical stock had its Relative Strength (RS) Rating upgraded to 87 from 77. 
Via Investor's Business Daily
7 Biotech Stocks to Boost Your Portfolio to Peak Health
With biotech stocks commanding a permanently relevant narrative, you can’t afford to ignore these highly endorsed ideas. 
Via InvestorPlace
Tesla, Alphabet, GM, Ford Lead Earnings Parade This Week As Market Struggles To Sustain The Summer Rally
The earnings parade continues this week with a slightly accelerated tempo as analysts brace for a healthy reporting season. 
Via Benzinga
3 Record-Breaking Stocks With More Room to Run
These three top record-breaking stocks have more upside ahead, driven by analysts' Strong Buy recommendations. 
Via InvestorPlace
Boston Scientific to Acquire Silk Road Medical in $1.16 billion USD Merger and Acquisition (M&A) Deal
Via AB Newswire
Boston Scientific Adds Stroke Prevention To Vascular Portfolio Via Silk Road Medical's $1.3B Deal
Boston Scientific to acquire Silk Road Medical for $1.26 billion, enhancing its vascular portfolio with Silk Road's TCAR system, a breakthrough in stroke prevention. Transaction closes in H2 2024. 
Via Benzinga
Why Is Silk Road Medical (SILK) Stock Up 24% Today?
Silk Road Medical stock is up on Tuesday after Boston Scientific announced its acquiring the company in a $1.26 billion deal. 
Via InvestorPlace
Silk Road Medicine Rockets On Boston Scientific's $1.16 Billion Takeover
The deal focuses on the company's stroke prevention product for patients with carotid artery disease. 
Via Investor's Business Daily
Silk Road Medical Announces Definitive Agreement to be Acquired by Boston Scientific
From Silk Road Medical
Via GlobeNewswire
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks just under the surface and warrant attention. 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.